Skip to Main Content
University Libraries serving
School of Health and Medical Sciences
School of Medicine
College of Nursing
Toggle navigation
Search our website
Find
Databases
eBooks
eJournals
e-Repository - SHU Scholarship
IHS Campus Faculty Publications
PubMed
Services
My Accounts
Consult with a Librarian
Events & Classes
Data Services
Interlibrary Borrowing
Dissertation & Theses
Reserve a Study Space
Toolkits
For Medical Students
For Nursing Students
For SHMS Students
For Faculty
How-to Guides
All Toolkits
About Us
Locations and Hours
IHS Library Directory
Mission & History
Rules
FAQs
Giving to the IHS Library
School of Medicine Faculty Publications Database
Welcome
Journal Articles
Conferences
Oncology
Andre Goy, M.D., M.S.
Chair of Oncology
Email
Department of Oncology Faculty Publications (By Year)
2021
2020
2019
2018
Advani, R. H., Moskowitz, A. J., Bartlett, N. L., Vose, J. M., Ramchandren, R.,
Feldman, T. A.
, . . . Herrera, A. F. (2021). Brentuximab vedotin in combination with nivolumab in relapsed or refractory hodgkin lymphoma: 3-year study results.
Blood
, 138(6), 427-438. doi:10.1182/blood.2020009178
Berry, D. A., Ip, A.,
Lewis, B. E.
, Berry, S. M., Berry, N. S., MrKulic, M., . . . Goldberg, S. L. (2021). Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19.
PLoS ONE
, 16(7 July) doi:10.1371/journal.pone.0255228
Leslie, L. A.
(2021). Novel therapies for follicular lymphoma and other indolent non-hodgkin lymphomas.
Current Treatment Options in Oncology
, 22(12) doi:10.1007/s11864-021-00909-1
Zayac, A. S., Evens, A. M., Danilov, A., Smith, S. D., Jagadeesh, D.,
Leslie, L. A.
, . . . Olszewski, A. J. (2021). Outcomes of burkitt lymphoma with central nervous system involvement: Evidence from a large multicenter cohort study.
Haematologica
, 106(7), 1932-1942. doi:10.3324/haematol.2020.270876
Feldman, T.
, Zou, D., Rebeira, M., Lee, J., Fanale, M., Manley, T., . . . Kansal, A. (2020). Cost-effectiveness of brentuximab vedotin with chemotherapy in treatment of CD30-expressing PTCL.
American Journal of Managed Care
, 26(2), E41-E49.
Leslie, L. A.
(2020). Clinical use of emerging therapies in relapsed or refractory follicular lymphoma.
Clinical Advances in Hematology & Oncology : H&O
, 18(12), 15-19.
Mato, A. R., Roeker, L. E., Lamanna, N., Allan, J. N.,
Leslie, L.
, Pagel, J. M., . . . Eyre, T. A. (2020). Outcomes of COVID-19 in patients with CLL: A multicenter international experience.
Blood
, 136(10), 1134-1143. doi:10.1182/blood.2020006965
Pagel, J. M., Burke, J. M., &
Leslie, L. A.
(2020). Refining the management of relapsed or refractory follicular lymphoma.
Clinical Advances in Hematology & Oncology : H&O
, 18(12), 1-24.
Pagel, J. M., Burke, J. M., &
Leslie, L. A.
(2020). Refining the management of relapsed or refractory follicular lymphoma: Case scenarios.
Clinical Advances in Hematology & Oncology : H&O
, 18(12), 20-21.
Roeker, L. E., Knorr, D. A., Pessin, M. S., Ramanathan, L. V., Thompson, M. C.,
Leslie, L. A.
, . . . Mato, A. R. (2020). Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
Leukemia
, 34(11), 3047-3049. doi:10.1038/s41375-020-01030-2
Bair, S. M., Strelec, L. E.,
Feldman, T. A.
, Ahmed, G., Armand, P., Shah, N. N., . . . Svoboda, J. (2019). Outcomes and toxicities of programmed death-1 (PD-1) inhibitors in hodgkin lymphoma patients in the united states: A real-world, multicenter retrospective analysis.
Oncologist
, 24(7), 955-962. doi:10.1634/theoncologist.2018-0538
Chihara, D., Wong, S.,
Feldman, T.
, Fanale, M. A., Sanchez, L., Connors, J. M., . . . Oki, Y. (2019). Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.
Hematological Oncology
, 37(1), 35-38. doi:10.1002/hon.2560
Leslie, L. A.
,
Feldman, T. A.
, McNeill, A., Timberg, M., Iida, H., & Goy, A. H. (2019). Contemporary management of nodal and primary splenic marginal zone lymphoma.
Expert Review of Hematology
, 12(12), 1011-1022. doi:10.1080/17474086.2020.1681962
Nowakowski, G. S.,
Feldman, T.
, Rimsza, L. M., Westin, J. R., Witzig, T. E., & Zinzani, P. L. (2019). Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma.
Blood Cancer Journal
, 9(6) doi:10.1038/s41408-019-0208-6
Herrera, A. F., Moskowitz, A. J., Bartlett, N. L., Vose, J. M., Ramchandren, R.,
Feldman, T. A.
, . . . Advani, R. H. (2018). Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory hodgkin lymphoma.
Blood
, 131(11), 1183-1194. doi:10.1182/blood-2017-10-811224